Retrieved from Patel, F., Gan, A., Chang, K., & Vega, K
Unlike some of the other GLP-1 receptor agonists, this Exenatide injection requires administration twice daily
The role of CD26/dipeptidyl peptidase IV in cancer
Sin embargo, un metaanlisis que evalu a los diferentes ISLGT2 encontr que los estudios con CANA tenan una mayor heterogeneidad lo que no permite afirmar que su eficacia hipoglicemiante sea superior113
Track your progress, access personalized educational content, and stay in touch with your clinician all in one place
No systemic side effects were consistently reported across any of the studies